スポンサーリンク
Department Of Thoracic Malignancy Osaka Prefectural Medical Center For Respiratory And Allergic Dise | 論文
- Imatinib mesylate inhibited rat adjuvant arthritis and PDGF-dependent growth of synovial fibroblast via interference with the Akt signaling pathway
- Suppressor of cytokine signaling-1 ameliorates dextran sulfate sodium-induced colitis in mice
- Preventative Effect of a Flavonoid, Enzymatically Modified Isoquercitrin on Ocular Symptoms of Japanese Cedar Pollinosis
- Determinants of Myelosuppression in the Treatment of Non-small Cell Lung Cancer with Cisplatin-containing Chemotherapy
- Phase I and Pharmacokinetics Trial of BNP7787 in Patients Receiving Cisplatin and Paclitaxel
- Relationship between the Pharmacokinetics of Irinotecan and Diarrhea during Combination Chemotherapy with Cisplatin
- E-22 Establishment of Tumor Cell Lines as An Independent Prognostic Factor in Small Cell Lung Cancer (SCLC)
- 65 Seven Small Cell Lung Cancer (SCLC) Cell Lines established from Bronchofiberscope Biopsies
- Inadequate induction of suppressor of cytokine signaling-1 causes systemic autoimmune diseases
- Radiation Pneumonitis following Multi-Field Radiation Therapy
- Non-small cell lung cancer : radiation therapy for locoregional recurrence after complete resection
- Proteomics-based identification of α-enolase as a tumor antigen in non-small lung cancer
- Preliminary experience with a modified premedication protocol that included intravenous diphenhydramine and calcium bromide for the prophylaxis of paclitaxel-related hypersensitivity reactions
- SOCS-1 suppresses TNF-α-induced apoptosis through the regulation of Jak activation
- A regulatory role for suppressor of cytokine signaling-1 in T_h polarization in vivo
- Carboplatin Calculated with Chatelut's Formula Plus Etoposide for Elderly Patients with Small-Cell Lung Cancer
- Phase I study of weekly cisplatin, vinorelbine, and concurrent thoracic radiation therapy in patients with locally advanced non-small-cell lung cancer
- A Single Institutional Subset Analysis of the WJLCG Study Comparing Concurrent and Sequential Chemoradiotherapy for Stage III Non-small-cell Lung Cancer
- Comparison of chemotherapy regimens for concurrent chemoradiotherapy in unresectable stage III non-small cell lung cancer
- Evaluation of S-1 as third- or further-line chemotherapy in advanced non-small-cell lung cancer